AstraZeneca

British-Swedish pharmaceutical company

AstraZeneca ▸ Facts ▸ Comments ▸ News ▸ Videos

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It is perhaps best known for its involvement in developing the Oxford-Astrazeneca COVID-19 vaccine.

1 shares	Share Tweet Save Post Send


EU-AstraZeneca row: both claim victory after Belgian court ruling Credit: FRANCE 24 English Duration: 04:34Published 4 days ago

Boris Johnson pledges one billion vaccinations UK Prime Minister Boris Johnson has pledged one billion doses of the Astra Zeneca vaccine for world wide distribution on behalf of the G7 governments in an effort to accelerate global vaccination... Credit: ODN Duration: 01:30Published 1 week ago


Boris Johnson receives second Covid vaccine dose Prime Minister Boris Johnson has received his second dose of AstraZeneca’s coronavirus vaccine at the Francis Crick Institute in London on Thursday evening. Credit: PA - Press Association STUDIO Duration: 01:31Published 3 weeks ago

EU seeks huge fine in court over AstraZeneca vaccine delivery delays After months of a bitter dispute over vaccine delivery delays between the European Union and AstraZeneca, a highly publicised trial opened on Wednesday in Brussels. Credit: euronews (in English) Duration: 02:20Published on May 27, 2021

Coronavirus pandemic: EU and Astrazeneca battle in court over vaccine delays Credit: FRANCE 24 English Duration: 03:52Published on May 26, 2021

Vaccine in numbers: UK passes 60m jabs milestone More than 60 million vaccine doses have now been administered in the UK.It comes as a study found the Pfizer and AstraZeneca vaccines are highly effective after two doses against the variant identified.. Credit: PA - Press Association STUDIO Duration: 00:37Published on May 23, 2021

Coronavirus: Pfizer and AstraZeneca jabs effective against Indian variant A study has found the Pfizer and AstraZeneca coronavirus vaccines are highly effective against the variant identified in India after two doses.Health Secretary Matt Hancock said the findings made him.. Credit: PA - Press Association STUDIO Duration: 01:18Published on May 23, 2021

Daily politics briefing: May 23 The key facts behind the day's headlines as both the Pfizer and AstraZeneca jabs were found to be highly effective against the B1617.2 strain. Credit: PA - Press Association STUDIO Duration: 00:47Published on May 23, 2021

Kenya's health minister: Africa 'must stop believing' world will help CNN’s Larry Madowo speaks with Kenyan health minister Mutahi Kagwe as the East African nation is now just days away from running out of Covid-19 vaccines, with only about 100,000 AstraZeneca doses.. Credit: Bleacher Report AOL Duration: 02:30Published on May 19, 2021

Biden announces US will share more vaccines globally President Joe Biden announced that his administration will share millions more doses of Covid-19 vaccines with other countries in addition to the 60 million doses of the AstraZeneca vaccine he has.. Credit: Bleacher Report AOL Duration: 02:12Published on May 17, 2021

Mixing Covid-19 vaccines 'could increase side effects' Researchers from the Oxford Vaccine Group's Com-COV vaccine trial discovered that adults were more likely to suffer from mild to moderate side effects after mixing doses of the AstraZeneca and Pfizer.. Credit: Cover Video STUDIO Duration: 01:22Published on May 13, 2021

Vaccine in numbers: More than 18 million second jabs given More than 18 million second coronavirus jabs have been given in the UK, along with 35,587,348 first doses. The statistics come after protesters demanded that AstraZeneca share its Covid-19 vaccine.. Credit: PA - Press Association STUDIO Duration: 00:37Published on May 11, 2021

European Union opts not to renew AstraZeneca vaccines contract after supply row Commissioner Thierry Breton says a post-June order has not been made as French President Emmanuel Macron says the bloc will focus on different vaccines Credit: euronews (in English) Duration: 01:00Published on May 10, 2021

Taoiseach receives AstraZeneca vaccine The Taoiseach expressed hope that Ireland can look forward to a good summer as he received his first Covid-19 vaccination.Micheal Martin was given an AstraZeneca jab at the Cork City Hall vaccination.. Credit: PA - Press Association STUDIO Duration: 00:30Published on May 9, 2021

Age threshold for alternative to AstraZeneca jab raised Under-40s are to be offered an alternative to the Oxford/AstraZeneca Covid-19 vaccine as a precautionary move. Credit: PA - Press Association STUDIO Duration: 00:38Published on May 7, 2021

Under-40s in UK to get alternative Covid jab to AstraZeneca Under-40s in the UK will be offered an alternative coronavirus vaccine to the Oxford/AstraZeneca jab. The Joint Committee on Vaccination and Immunisation (JCVI) said there is an "extremely small risk".. Credit: ODN Duration: 01:00Published on May 7, 2021

Vaccine production is truly international collaboration in India: EAM Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other.. Credit: ANI Duration: 01:57Published on May 5, 2021

UK agreed to expand partnership on vaccines: MEA Prime Minister Narendra Modi held a virtual summit with his UK counterpart Boris Johnson on May 04. Speaking on the talks between the two leaders, MEA Joint Secretary (Europe West), Sandeep Chakraborty.. Credit: ANI Duration: 01:13Published on May 4, 2021

Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge Maharashtra Congress Chief chief Nana Patole has responded to SII chief Adar Poonawalla’s allegation that he is being threatened. Addressing the media, Patole said that Congress is worried over.. Credit: HT Digital Content Duration: 02:05Published on May 3, 2021

‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls Serum Institute of India CEO Adar Poonawalla, who has been in the UK on extended stay to evade alleged threats in India over ever-increasing demand for COVID-19 vaccines, has said he will return in a.. Credit: HT Digital Content Duration: 01:50Published on May 2, 2021

‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India Serum Institute of India CEO Adar Poonawalla on Saturday spoke out about the pressures he was under over the production of COVID-19 vaccines to meet the ever-increasing demand in India as the country.. Credit: HT Digital Content Duration: 01:43Published on May 1, 2021

Europe's week: Vaccine passports, Brexit, Sofagate and AstraZeneca These are the key stories from the Brussels bubble this week. Credit: Euronews English Duration: 07:00Published on April 30, 2021

You Might Like

Vietnam to receive 1 million doses of AstraZeneca vaccine weekly from July IndiaTimes - Published 5 hours ago
AstraZeneca top expert backs India on widening Covishield dose gap IndiaTimes - Published 3 days ago
When should you take second dose of Covishield vaccine? AstraZeneca says THIS AstraZeneca on Friday backed the idea of keeping a 12-16 weeks gap between the two doses of the Covishield vaccine. DNA - Published 3 days ago

AstraZeneca vaccine's chief investigator backs India's 12-16 week Covishield dose gap IndiaTimes - Published 4 days ago
AstraZeneca and EU both claim win as court rules on vaccine supply row AstraZeneca and the EU have both claimed victory in a court ruling over the supply of COVID-19 vaccines. Sky News - Published 4 days ago
Covishield produces more antibodies than Covaxin, finds study Covishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by Hyderabad-based Bharat Biotech in.. IndiaTimes - Published 2 weeks ago

US to ease Covid vaccine input supply: Kamala Harris to PM Modi US Vice-President Kamala Harris on Thursday spoke to PM Narendra Modi to brief him about the Biden administration’s new vaccine policy that will clear supply chains for AstraZeneca and Novavax.. IndiaTimes - Published 3 weeks ago
Boris Johnson receives second dose of AstraZeneca COVID vaccine Boris Johnson has had his second dose of the AstraZeneca COVID vaccine. Sky News - Published 3 weeks ago
UK government negotiating with AstraZeneca to secure South African variant vaccine The UK government has begun negotiations with AstraZeneca to secure a "variant vaccine" that can tackle the South African variant, Health Secretary Matt Hancock has said. Sky News - Published 3 weeks ago
US redirects vaccine manufacturing supplies allowing India to make additional 20 million Covid vaccine doses The US government on Friday redirected orders of critical vaccine manufacturing supplies, which will allow India to make over 20 million additional doses of AstraZeneca Covid-19 vaccines. IndiaTimes - Published 3 weeks ago

ICMR to examine effectiveness of AstraZeneca's Covishield and Bharat Biotech's Covaxin IndiaTimes - Published on May 26, 2021
Small number of people suffer stroke after AstraZeneca jab - as experts urge doctors to be alert Doctors have been told to look out for signs of stroke in patients who received the Oxford/AstraZeneca coronavirus jab after one person died and two others needed hospital treatment. Sky News - Published on May 26, 2021
Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of Covid-19, first discovered in India, a new UK.. IndiaTimes - Published on May 22, 2021	'It would be a disaster': Vaccine hesitancy in some African nations risks jabs going out of date When the world-wide vaccine alliance, GAVI, announced that 132,000 AstraZeneca vaccines had been designated for South Sudan, doctors and health officials in this impoverished country were both.. Sky News - Published on May 22, 2021
3-month gap between doses improves immune response: AZ vax co-developer A three-month gap between two doses of the AstraZeneca vaccine, known in India as Covishield, improves the immune response against Covid-19, according to Andrew Pollard, co-developer of the vaccine and.. IndiaTimes - Published on May 18, 2021	'Morally wrong' to offer COVID jabs to children while poorer nations suffer, says Oxford expert It is "morally wrong" to offer coronavirus jabs to children in wealthy countries when people at greater risk in poorer nations remain unvaccinated, one of the scientists behind the Oxford-AstraZeneca.. Sky News - Published on May 18, 2021
Biggest AstraZeneca jab maker unlikely to resume exports 'for at least three months' The world's biggest maker of the AstraZeneca vaccine is unlikely to resume major exports until at least October as it prioritises doses for India's coronavirus crisis. Sky News - Published on May 18, 2021	26 cases of blood clotting, bleeding due to AstraZeneca vaccine in India: Govt IndiaTimes - Published on May 17, 2021
Under-40s to be offered alternative to Oxford jab over blood clot fears All under-40s are to be offered an alternative to the Oxford/AstraZeneca coronavirus vaccine as a precaution. Sky News - Published on May 7, 2021	US 'doing a lot for India' to meet Covid crisis: Joe Biden President Joe Biden has said that the US was "doing a lot for India" by sending it oxygen and materials to make anti-Covid-19 vaccines. Biden's spokesperson Jen Psaki said that the US government was.. IndiaTimes - Published on May 5, 2021
Sweden plans to donate 1 million doses of AstraZeneca vaccines to India Sweden plans to donate 1 million doses of AstraZeneca vaccines to India via the UN-backed COVAX, an initiative devised to give countries access to coronavirus vaccines regardless of their wealth. IndiaTimes - Published on May 3, 2021	Serum Institute plans to start Covid vaccine production outside India: Report The Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief.. IndiaTimes - Published on May 1, 2021
5 million doses of COVID-19 vaccine Sputnik V in India by June, says Indian envoy to Russia Venkatesh Varma New Delhi: India is set to get 5 million doses of Russian COVID vaccine Sputnik V by June, even as the vaccine is set to be rolled in the country from May 1. Sputnik V is the third vaccine India has.. DNA - Published on May 1, 2021	India's COVID crisis: US to redirect 20M doses of AstraZeneca vaccines, send raw material to make 5,00,000 doses Over the weekend, the US announced that it will be diverting raw material to India for manufacturing of COVID-19 vaccines in the country. DNA - Published on April 29, 2021
US to share up to 60 million doses of AstraZeneca vaccine with the world The US will share up to 60 million doses of the AstraZeneca vaccine with the world, the White House has said. Sky News - Published on April 26, 2021	EU Commission sues AstraZeneca over vaccine contract The European Commission has launched legal action against AstraZeneca for not respecting a contract for the supply of COVID-19 vaccines. Sky News - Published on April 26, 2021
EU takes legal action against AstraZeneca over vaccine supply A legal case has been started by the European Commission against AstraZeneca over its "complete failure" to meet delivery and contractual agreements, Ireland's health minister has said. Sky News - Published on April 22, 2021	How big is risk of clots from Covishield? The risk is extremely low, and the link between blood clots and the Oxford-AstraZeneca vaccine is still not 100% clear. Also, the clots can be treated if patients report them early. IndiaTimes - Published on April 21, 2021
UNICEF says AstraZeneca supply issues outside India resolved IndiaTimes - Published on April 20, 2021	Family of Italian woman who died after Oxford jab launch legal action The family of an Italian woman who died weeks after having the Oxford-AstraZeneca coronavirus vaccine have told Sky News they are taking legal action to establish whether the jab was to blame. Sky News - Published on April 18, 2021
Risk of blood clot after COVID is eight times higher than after AstraZeneca jab - study The risk of developing a blood clot after having COVID-19 is eight times higher than after being given the Oxford-AstraZeneca vaccine, according to a study by Oxford University. Sky News - Published on April 15, 2021	European Medicines Agency issues post-vax adverse-event alert for medics The safety committee of the European Medicines Agency (EMA) has asked those receiving the AstraZeneca vaccine (called Covishield in India) and medical professionals to look out for cases of unusual.. IndiaTimes - Published on April 11, 2021
'It's been a massive achievement': Former AstraZeneca board member defends firm over vaccine A former AstraZeneca board member has told Sky News that she thinks the company has been unfairly criticised over its handling of the vaccine rollout. Sky News - Published on April 11, 2021	India to review Covid-19 vaccines after blood clot warning: Report A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two Covid-19 vaccines being administered in India, a media report said.. IndiaTimes - Published on April 9, 2021
Blood clot victim's sister 'very angry' but says everyone should have Oxford jab The sister of a man who died from a blood clot after receiving the Oxford-AstraZeneca vaccine has said she is "very angry" but still "strongly" believes people should have the vaccine. Sky News - Published on April 8, 2021	More than 700,000 doses of AstraZeneca jab 'flown from UK to Australia' More than 700,000 doses of the Oxford-AstraZeneca vaccine have been flown from the UK to Australia, it has been reported. Sky News - Published on April 8, 2021
Oxford jab scientist set for £20m windfall in 'New York flotation' The scientist who led the development of the Oxford University-AstraZeneca coronavirus vaccine is on course for a payday of more than £20m through a stock market listing, according to reports. Sky News - Published on April 8, 2021	'Full speed ahead' for vaccine rollout - but 18 to 29-year-olds to be offered alternative to Oxford jab Boris Johnson has said the roadmap out of lockdown will not be affected by the decision to offer 18 to 29-year-olds an alternative to the Oxford-AstraZeneca vaccine. Sky News - Published on April 8, 2021
AstraZeneca sends legal notice to SII over delays in vaccine supply IndiaTimes - Published on April 8, 2021	What is the AstraZeneca blood clot risk and how does it compare? The use of the Oxford-AstraZeneca vaccine in those under 30 is to be limited due to concerns over blood clots - but what exactly is the risk and how does it compare? Sky News - Published on April 7, 2021
Serum Institute asks government for $403 million to boost AstraZeneca vaccine output The Serum Institute of India has asked the government for a grant of 30 billion rupees ($402.97 million) to increase its capacity to make AstraZeneca's Covid-19 vaccine. It is seeking the money to ramp.. IndiaTimes - Published on April 7, 2021	'Unusual blood clots' should be listed as 'very rare' side effect of Oxford vaccine, EU regulator says The European medicines regulator says that "unusual blood clots" should be listed as "very rare" side-effects of the Oxford-AstraZeneca COVID vaccine. Sky News - Published on April 7, 2021
Britons aged 18-29 to be offered alternative to Oxford jab Britons aged 18-29 will be offered an alternative to the Oxford-AstraZeneca vaccine where available, government advisors have decided. Sky News - Published on April 7, 2021	Does the AstraZeneca vaccine still pass the risk-benefit analysis for young people? The greater the risk of a disease, the greater the risk doctors would be prepared to take to prevent it. Sky News - Published on April 7, 2021
Everything you need to know about the Moderna vaccine The Moderna coronavirus vaccine is the third jab to be rolled out in the UK, alongside the Pfizer/BioNTech and Oxford University-AstraZeneca jabs. Sky News - Published on April 7, 2021	UK trial of Oxford COVID jab on children paused as regulator probes blood clots in adults A trial of the Oxford-AstraZeneca COVID vaccine on children in the UK has been paused while the medicines regulator investigates a possible link between the jab and rare blood clots in adults. Sky News - Published on April 6, 2021
EU medical regulator's chief: 'Increasingly difficult' to say no link between Oxford jab and rare blood clots The head of the European Medicines Agency (EMA) has said it is "increasingly difficult" to say there is "no cause and effect relationship" between the Oxford-AstraZeneca jab and "rare cases of unusual.. Sky News - Published on April 6, 2021

AstraZeneca

British-Swedish pharmaceutical company

AstraZeneca ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Vietnam to receive 1 million doses of AstraZeneca vaccine weekly from July

AstraZeneca top expert backs India on widening Covishield dose gap

When should you take second dose of Covishield vaccine? AstraZeneca says THIS

AstraZeneca vaccine's chief investigator backs India's 12-16 week Covishield dose gap

AstraZeneca and EU both claim win as court rules on vaccine supply row

Covishield produces more antibodies than Covaxin, finds study

US to ease Covid vaccine input supply: Kamala Harris to PM Modi

Boris Johnson receives second dose of AstraZeneca COVID vaccine

UK government negotiating with AstraZeneca to secure South African variant vaccine

US redirects vaccine manufacturing supplies allowing India to make additional 20 million Covid vaccine doses

ICMR to examine effectiveness of AstraZeneca's Covishield and Bharat Biotech's Covaxin

Small number of people suffer stroke after AstraZeneca jab - as experts urge doctors to be alert

Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study

'It would be a disaster': Vaccine hesitancy in some African nations risks jabs going out of date

3-month gap between doses improves immune response: AZ vax co-developer

'Morally wrong' to offer COVID jabs to children while poorer nations suffer, says Oxford expert

Biggest AstraZeneca jab maker unlikely to resume exports 'for at least three months'

26 cases of blood clotting, bleeding due to AstraZeneca vaccine in India: Govt

Under-40s to be offered alternative to Oxford jab over blood clot fears

US 'doing a lot for India' to meet Covid crisis: Joe Biden

Sweden plans to donate 1 million doses of AstraZeneca vaccines to India

Serum Institute plans to start Covid vaccine production outside India: Report

5 million doses of COVID-19 vaccine Sputnik V in India by June, says Indian envoy to Russia Venkatesh Varma

India's COVID crisis: US to redirect 20M doses of AstraZeneca vaccines, send raw material to make 5,00,000 doses

US to share up to 60 million doses of AstraZeneca vaccine with the world

EU Commission sues AstraZeneca over vaccine contract

EU takes legal action against AstraZeneca over vaccine supply

How big is risk of clots from Covishield?

UNICEF says AstraZeneca supply issues outside India resolved

Family of Italian woman who died after Oxford jab launch legal action

Risk of blood clot after COVID is eight times higher than after AstraZeneca jab - study

European Medicines Agency issues post-vax adverse-event alert for medics

'It's been a massive achievement': Former AstraZeneca board member defends firm over vaccine

India to review Covid-19 vaccines after blood clot warning: Report

Blood clot victim's sister 'very angry' but says everyone should have Oxford jab

More than 700,000 doses of AstraZeneca jab 'flown from UK to Australia'

Oxford jab scientist set for £20m windfall in 'New York flotation'

'Full speed ahead' for vaccine rollout - but 18 to 29-year-olds to be offered alternative to Oxford jab

AstraZeneca sends legal notice to SII over delays in vaccine supply

What is the AstraZeneca blood clot risk and how does it compare?

Serum Institute asks government for $403 million to boost AstraZeneca vaccine output

'Unusual blood clots' should be listed as 'very rare' side effect of Oxford vaccine, EU regulator says

Britons aged 18-29 to be offered alternative to Oxford jab

Does the AstraZeneca vaccine still pass the risk-benefit analysis for young people?

Everything you need to know about the Moderna vaccine

UK trial of Oxford COVID jab on children paused as regulator probes blood clots in adults

EU medical regulator's chief: 'Increasingly difficult' to say no link between Oxford jab and rare blood clots